Development of Effective Biomarkers for Cancer Detection is Crucial Says New Report

Debi wrote an interesting post today on
Here’s a quick excerpt
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report showing that until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis.

“Biomarker Technology Platforms for Cancer Diagnoses and Therapies” reports that in the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred.
The report shows that the case is clear for development of biomarkers for early detection and screening tests for diseases such as breast, colon, ovarian and lung cancer. In addition, diagnostic measurement of cancer disease progression is essential to successful disease management. For these reasons, development of new and effective biomarkers for cancer detection and diagnosis is central to the cancer problem

Read the rest of this great post here

Leave a Reply